stockrow
Friday 6 November 2026
Export AVR’s income statement to Excel — free account
Anteris Technologies Global Corp.
AVR Healthcare Medical Devices
Anteris Technologies Global Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, down 29.2% from fiscal 2024.
- Revenue
- +63.3%
- EPS
- +48.3%
- Free cash flow
- −6.84%
- Total debt
- +8.15%
Quarter to June 2026, against a year earlier
5.64
0.06
+1.08%
Follow AVR
Alert me
Anteris Technologies Global Corp. (AVR) P/E ratio
Anteris Technologies Global Corp. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 6 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SENS Senseonics Holdings, Inc. compare | n/m |
| SGHT Sight Sciences, Inc. compare | n/m |
| CERS Cerus Corporation compare | n/m |
| CTKB Cytek Biosciences, Inc. compare | n/m |
| AVR Anteris Technologies Global Corp. | n/m |
| NPCE NeuroPace, Inc. compare | n/m |
| MASS 908 Devices Inc. compare | n/m |
| TCMD Tactile Systems Technology, Inc. compare | 25.2× |
| DCTH Delcath Systems, Inc. compare | 1,455× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)